01 — At a Glance
The Pediatric Unicorn That Discovered Gravity
- 52-Week High / Low₹1,646 / ₹1,009
- FY25 Revenue (Full Year)₹1,516 Cr
- FY25 PAT (Full Year)₹244 Cr
- Full-Year EPS (FY25)₹23.97
- Q3 EPS (Annualised Q3×4)₹28.56
- Book Value₹149
- Price to Book7.62x
- Dividend Yield0.26%
- Debt / Equity0.54x
- Operating Margin31.9%
The Plot So Far: Rainbow clocked ₹1,243 crore revenue in 9M FY26 (+9% YoY), ₹203.3 crore PAT (+8.3% YoY), and 31.9% operating margins. Sounds fantastic until you realize occupancy plunged to 47.2% because — wait for it — children weren’t getting sick this season. Volume growth: +9% IP, +18% OP, +16% deliveries. The stock, meanwhile, is down 19.7% in six months. Markets apparently didn’t read the management concall where Rainbow explained this was “unusual” seasonality. Translation: we miscalculated demand. We’re fixing it. Please don’t sell.
02 — Introduction
Where Pediatricians Learned That Children Have Off-Seasons
Rainbow Children’s Medicare is India’s largest pediatric hospital chain. Not largest by revenue. Largest by sheer audacity to build an entire healthcare empire around children and mothers when every rational investor asked: “But what happens in summer when kids don’t get pneumonia?”
Founded in 1999 in Hyderabad by the Kancharla family, Rainbow now operates 22 hospitals across 9 cities, 2,285 beds, 1,000+ doctors, and serves roughly 750,000+ outpatient visits annually. The brand equity is legitimately South India–centric (Hyderabad = 8 hospitals, Bengaluru = 4, Chennai = 3). They specialize in what sounds like niche services until you realize obstetrics and pediatrics represent 60–70% of all hospital bed demand in developing countries.
Q3 FY26 dropped like a medical gaffe. Occupancy at 47.2%. That’s not strategy; that’s a cry for help. Management blamed “unusual” muted pediatric seasonality. Translation: monsoon didn’t bring respiratory infections. Summer doesn’t bring bacterial infections. The playbook failed. So they appointed a new CEO, Abrarali Dalal, effective Jan 20, 2026, to “fix” occupancy. Are we excited? Let’s see the data first. Hype later.
The stock trades at 45x P/E, the most expensive healthcare name in India. For context, Apollo Hospitals trades at 60x (larger, more complex), Max Healthcare at 67x (more diversified). Rainbow is betting everything on expansion into new cities, ramp-up of newly commissioned beds, and occupancy recovery. If they execute — great. If they don’t — this valuation will evaporate faster than a pediatric patient’s trust in a needle-carrying doctor.
Management Feb 2026 Concall: “Our objective is to improve occupancy to around 55%–60%.” Which is wild because 55% occupancy isn’t excellence. It’s where they were in 2022. They’ve built 950–1,000 new beds in the last three years and now want to re-fill the old ones. Priorities.
03 — Business Model: Why Pediatrics? Because ‘General Medicine’ Was Too Boring
They Treat Babies. Toddlers. Mothers. And Anxiety.
Rainbow’s entire model hinges on one insight: pediatric and obstetrics healthcare in India is fragmented, underserved, and growing. A family willing to pay ₹5,000 for a regular hospital bed will pay ₹12,000–₹15,000 for a specialized pediatric ICU. Insurance empanelment is easy. Brand loyalty is high. The customer (parents) will travel 200 km if it means their child gets care that doesn’t hurt. Rainbow monetized this by building obstetrics and pediatric “super-specialized” care. No cardiology. No orthopedics. Just mothers and kids.
Revenue split is roughly 51% insurance, 49% cash. They operate a hub-and-spoke model in South India: large central hubs (150–250 beds) in metros, smaller spokes (50–100 beds) in tier-II cities. Beds are specialized — one-third are ICU. ARPOB (Average Revenue Per Occupied Bed) sits at ₹57,396/day. That’s legitimately high-margin if you fill them. The problem? Filling them requires patients, and patients require seasonality. Kids get sick in monsoons. Mothers deliver more in certain months. Ignoring this reality while building 950 beds in three years was, in hindsight, ambitious.
Recent expansions: Rajahmundry (100 beds, commissioned Q3, “exceptional” per management). Electronic City, Bengaluru (90 beds, “just commenced operations”). Acquisitions: Warangal (Prashanthi, 100 beds, ₹32.6 Cr), Guwahati (Pratiksha, 200+ beds, ₹171 Cr). In the pipeline: Coimbatore (130 beds), Gurgaon (450 beds, 18–24 months away), Pune (150 beds). The capex? ₹950–1,000 crore over three years. Entirely self-funded. Cash balance: ₹579 crore. Interest Coverage: not an issue. Execution: the real question.
Hyderabad Base8 Hospitals36% of beds
Bengaluru Expansion4 HospitalsGrowing
Chennai + Andhra6 HospitalsRamp Phase
Total Bed Capacity2,285 BedsUp 18% YoY
Concentration Risk: Hyderabad drives 50%+ of company revenue. Multi-specialty players like Apollo and Fortis are now “re-entering mother-and-child care.” Smaller clinics are stealing OP footfalls in local geographies. Rainbow’s defensibility in complex pediatric cases is high. In OPD volume competition? They’re bleeding patients to convenience. This is why the new CEO’s mandate includes “significantly strengthened sales and marketing” — a euphemism for “we lost the local love.”
💬 If children’s hospitals only work when kids get seasonally sick, is the business model fundamentally broken during healthy years? Or is this just growing pains?
04 — Financials Overview
Q3 FY26: The Numbers (Read Them Twice)
Continue reading with a premium membership.
